Anti-CD152/CTLA4 Polyclonal Antibody from ProteoGenix; catalogue ARO-A22096; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Our Anti-CD152/CTLA4 Polyclonal Antibody is a highly specific and sensitive tool for the detection and analysis of CD152/CTLA4 protein expression in various biological samples. This antibody targets the CD152/CTLA4 protein, which plays a critical role in regulating immune responses and maintaining immune homeostasis.
CD152/CTLA4 is a cell surface protein that belongs to the immunoglobulin superfamily. It is primarily expressed on T cells and functions as a negative regulator of T cell activation. CD152/CTLA4 binds to its ligands, CD80 and CD86, on antigen-presenting cells, leading to the inhibition of T cell activation and proliferation. This mechanism helps to prevent excessive immune responses and maintain immune tolerance.
Our Anti-CD152/CTLA4 Polyclonal Antibody is widely used in various research areas, including immunology, cancer biology, and autoimmune diseases. It can be used for Western blotting, immunohistochemistry, flow cytometry, and other techniques to detect and quantify CD152/CTLA4 expression in different cell types and tissues.
– In cancer research, our antibody can be used to investigate the role of CD152/CTLA4 in tumor immunity and potential therapeutic strategies targeting this protein.
– In autoimmune disease studies, our antibody can help to understand the dysregulation of CD152/CTLA4 in autoimmune disorders and its potential as a therapeutic target.
– In immunology research, our antibody can be used to study the function of CD152/CTLA4 in immune tolerance, autoimmune diseases, and infectious diseases.
Overall, our Anti-CD152/CTLA4 Polyclonal Antibody is a valuable tool for researchers studying the role of CD152/CTLA4 in various biological processes. Its high specificity and sensitivity make it an essential reagent for accurate and reliable results. Order now and advance your research with confidence.
ProteoGenix catalogue number ARO-A22096. For research use only.
Target: Cytotoxic T-lymphocyte protein 4; Cytotoxic T-lymphocyte-associated antigen 4; CTLA-4; CD152; CTLA4; Clonality: Polyclonal Antibody; Applications: IHC, ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| Cytotoxic T-lymphocyte protein 4; Cytotoxic T-lymphocyte-associated antigen 4; CTLA-4; CD152; CTLA4 |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
